Kestra Advisory Services’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,395	Closed	-$117K	–	3123
2025 Q4	$117K	Buy	+4,395	New	+$105K	﹤0.01%	3308
2023 Q3	–	Sell	-8,403	Closed	-$201K	–	2107
2023 Q2	$201K	Buy	+8,403	New	+$187K	﹤0.01%	1904
2022 Q2	–	Sell	-8,596	Closed	-$208K	–	2130
2022 Q1	$208K	Buy	+8,596	New	+$208K	﹤0.01%	1825
2021 Q4	–	Sell	-10,438	Closed	-$173K	–	2006
2021 Q3	$173K	Sell	10,438 -152	-1%	-$2.93K	﹤0.01%	1994
2021 Q2	$258K	Sell	10,590 -1,071	-9%	-$24.2K	﹤0.01%	1670
2021 Q1	$301K	Sell	11,661 -3,942	-25%	-$174K	﹤0.01%	1465
2020 Q4	$838K	Buy	15,603 +2,753	+21%	+$137K	0.01%	941
2020 Q3	$530K	Buy	+12,850	New	+$555K	0.01%	858